| Trial name or title |
Blood Pressure Lowering in Acute Stroke Trial |
| Methods |
Randomised, double‐blind, placebo‐controlled |
| Participants |
Acute ischaemic stroke patients with elevated BP within 48 hours of symptom onset |
| Interventions |
Valsartan versus placebo orally daily for 7 days or until discharge |
| Outcomes |
30‐day Glasgow Outcome Scale, 30‐day modified Rankin scale and 30‐day Barthel Index |
| Starting date |
2007 |
| Contact information |
Gregory W Albers, Stanford University School of Medicine |
| Notes |
Funding: Stanford University, Novartis |
